Pharma Journalist 8769 posts 0 comments

HanAll Biopharma Co., Ltd., a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, has signed an exclusive licensing agreement…
Read More...

Johnson & Johnson announced it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage biotechnology company advancing a pipeline of immunology and…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for the investigational use of Sarclisa (isatuximab)…
Read More...

Celltrion today announced that the European Commission (EC) has approved Omlyclo (CT-P39), an omalizumab biosimilar referencing Xolair. Omlyclo is approved for the treatment of allergic…
Read More...

Biogen Inc. and Human Immunology Biosciences (HI-Bio), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated…
Read More...

Sandoz, the global leader in generic and biosimilar medicines, announced that the European Commission (EC) has granted marketing authorization for Wyost(denosumab) and Jubbonti…
Read More...

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical…
Read More...

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will…
Read More...

AltruBio Inc., a clinical stage biotechnology company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs,…
Read More...

Genmab A/S announced that it has completed its acquisition of ProfoundBio, Inc., a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADC)s and…
Read More...